Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBITDA Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed EBITDA Margin for 2 consecutive years, with 5603.19% as the latest value for Q1 2024.

  • For Q1 2024, EBITDA Margin changed N/A year-over-year to 5603.19%; the TTM value through Dec 2024 reached 26219.12%, changed N/A, while the annual FY2024 figure was 26219.12%, 2613429.0% down from the prior year.
  • EBITDA Margin hit 5603.19% in Q1 2024 for Artiva Biotherapeutics, down from 508.98% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 42.85% in Q3 2023 and bottomed at 5603.19% in Q1 2024.